查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018706

醫療設備分析測試外包市場：按測試類型、設備分類、設備類型、測試階段、技術、最終用戶和服務供應商分類－2026年至2032年全球市場預測

Medical Device Analytical Testing Outsourcing Market by Testing Type, Device Class, Device Type, Test Phase, Technology, End User, Service Provider - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療設備分析測試外包市場價值將達到 74.3 億美元，到 2026 年將成長至 79.8 億美元，到 2032 年將達到 133.8 億美元，複合年成長率為 8.77%。

主要市場統計數據
基準年 2025 74.3億美元
預計年份：2026年 79.8億美元
預測年份 2032 133.8億美元
複合年成長率 (%) 8.77%

在監管日益嚴格和技術主導的複雜性不斷增加的背景下，外包分析測試在醫療設備開發中的策略角色日益凸顯。

外包分析測試已從單純的成本削減措施演變為影響醫療設備研發路徑、法規遵循和市場准入的策略性職能。隨著醫療設備日益複雜，監管力度不斷加強，製造商和臨床試驗申辦方越來越依賴外部檢測實驗室提供專業的檢測方法、可追溯的分析方法以及符合全球申報標準的可靠數據包。因此，外包決策不再只是交易性的考量，而是產品規劃、品質策略和供應鏈韌性的核心要素。

技術、監管和供應鏈力量的相互作用，使得醫療設備分析和測試的外包模式需要重組，並需要新的夥伴關係模式。

醫療設備分析測試領域正經歷一場變革，其驅動力來自新技術、監管要求和經營模式的整合。高解析度儀器，例如質譜儀和先進顯微鏡，能夠對材料和生物相互作用進行更精細的表徵，從而提高了人們對測試結果的精確度和可重複性的期望。同時，資訊學和實驗室自動化的整合，在不影響資料可追溯性的前提下，縮短了測試週期，提高了檢測效率。

在提供分析測試服務時，我們將檢驗關稅趨勢的變化如何推動本地化、供應來源多元化和合約彈性。

關稅政策和貿易措施的變化會對外包分析檢測的成本基礎和營運模式產生重大影響，尤其是當實驗室依賴跨境供應設備、試劑和特殊耗材時。進口設備關稅的提高可能會延長設備升級的採購週期，迫使一些供應商推遲資本投資或尋找替代供應商。作為應對措施，檢測實驗室可能會調整特定服務項目的定價、與供應商重新談判合約或重組工作流程，以減少對受關稅影響的投入品的依賴。

細分市場主導的洞察將測試方法、醫療設備分類、開發階段和技術與採購政策和監管證據要求聯繫起來。

一套完善的細分框架有助於相關人員根據醫療設備的風險狀況、監管要求和商業性計劃調整其測試策略。根據測試類型，市場研究將測試分為生物測試、化學測試、微生物測試和物理測試，其中生物測試又細分為生物相容性測試、細胞毒性測試和血液相容性測試。這有助於明確植入式醫療設備面臨的具體生物安全性和材料交互作用挑戰。根據醫療設備類別，細分範圍擴展至 I 類、II 類和 III 類器械，這反映了監管的日益嚴格以及高風險類別所需的更深入的文檔和分析證據。

區域監管差異、臨床活動和當地能力如何影響檢測服務的採購慣例和預期差異？

區域趨勢對分析檢測服務的採購、交付和監管產生顯著影響。在美洲，監管協調和大規模的醫療技術生態系統支撐著多元化的供應商群體，快速交付、嚴格遵守可追溯性標準以及與北美臨床網路的互通性至關重要。這推動了對高通量分析服務和能夠支援上市前申報和上市後監測活動的跨學科實驗室的需求。

競爭動態表明，技術深度、監管專業知識和靈活的交付模式正在決定供應商的選擇和差異化。

分析檢測領域的領導者通常擁有深厚的技術專長、豐富的監管經驗和遍布全球的營運基地。頂尖供應商致力於方法開發、嚴格的驗證方案和資料管理系統，以確保可審計性和可重複性，從而能夠處理高風險醫療設備和複雜材料。這些供應商還組建了跨職能團隊，成員包括分析化學家、生物學家和法規科學家，負責將實驗室結果轉化為可報告的報告。

產業領導者可以採取切實有效的措施，使供應商合格、能力匹配和合約保障與專案目標保持一致。

為了將洞見轉化為行動，產業領導者應優先考慮以下三個切實可行的步驟。首先，加強供應商選擇框架，並透過強調分析方法驗證的可追溯性、儀器等效性和替代來源，確保在供應中斷期間測試的連續性。其次，投資於夥伴關係，利用內部能力進行關鍵檢測，並藉助外部專業知識進行處理能力和先進技術分析，從而最佳化資金配置並加快專案進度。

結合對從業人員的訪談、對監管指南的審查和技術檢驗的調查方法，確保了可操作和檢驗的見解。

本研究結合了實驗室負責人、法規遵循官員和採購負責人的訪談，以及對法規指導文件、設備供應商規格說明和公開科學文獻的二次分析。為確保研究結果能夠全面反映分析測試要求，研究優先考慮了在植入式醫療設備、診斷和複合材料產品領域擁有經驗的從業人員。二次檢驗的重點在於根據關鍵法規指導文件、同行評審的方法檢驗方案和技術白皮書，對能力和可重複性聲明進行交叉驗證。

結論是將分析測試從潛在的瓶頸轉變為醫療設備安全、合規和商業化的策略驅動力。

醫療設備的分析測試正變得日益重要，這要求製造商和服務供應商應對錯綜複雜的技術選擇、監管要求和供應鏈風險。對於所有器械分類和測試方法而言，確保數據的可重複性和可審計性至關重要，這些數據能夠經受監管審查，並支援及時做出有關研發和商業化的決策。因此，各組織必須超越單純的交易性採購，建立永續的夥伴關係關係，將卓越的技術與清晰的合約條款結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療設備分析與測試外包市場－測試類型

  • 生物學測試
    • 生物相容性測試
    • 細胞毒性試驗
    • 血液相容性測試
  • 化學測試
  • 微生物檢測
  • 實體測試

第9章：按設備類別分類的醫療設備分析與測試外包市場

  • 一級
  • 二類
  • 三級

第10章：醫療設備分析測試外包市場：依器材類型分類

  • 診斷設備
  • 藥物輸送裝置
  • 植入
    • 心血管植入
    • 植入
    • 整形外科植入
  • 監控設備
  • 手術器械

第11章：醫療設備分析與測試外包市場（依測試階段分類）

  • 臨床
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段
  • 臨床前

第12章：醫療設備分析測試外包市場：依技術分類

  • 層析法
    • 氣相層析法
    • 高效液相層析
  • 質譜分析
  • 顯微鏡
  • 光譜學

第13章：醫療設備分析測試外包市場：依最終用戶分類

  • 受委託的研究機構
  • 醫院和診所
  • 醫療設備製造商

第14章：醫療設備分析和測試外包市場（按服務供應商分類）

  • 受委託的研究機構
  • 內部研究機構

第15章：醫療設備分析測試外包市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：醫療設備分析測試外包市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：醫療設備分析測試外包市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國醫療設備分析測試外包市場

第19章：中國醫療設備分析測試及測試外包市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Avomeen Analytical Services
  • Bioreliance Corporation
  • Bureau Veritas SA
  • Charles River Laboratories International, Inc.
  • Element Materials Technology Group Ltd.
  • Eurofins Medical Device Testing
  • Eurofins Scientific SE
  • Gateway Analytical LLC
  • Intertek Group plc
  • Lucideon Limited
  • Medical Device Testing Services, Inc.
  • Medistri SA
  • Microbac Laboratories, Inc.
  • Nelson Laboratories, LLC
  • North American Science Associates, Inc.
  • Pacific Biolabs
  • SGS SA
  • Sterigenics US, LLC
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-AD36CD8982C3

The Medical Device Analytical Testing Outsourcing Market was valued at USD 7.43 billion in 2025 and is projected to grow to USD 7.98 billion in 2026, with a CAGR of 8.77%, reaching USD 13.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.43 billion
Estimated Year [2026] USD 7.98 billion
Forecast Year [2032] USD 13.38 billion
CAGR (%) 8.77%

Framing the strategic role of outsourced analytical testing in medical device development amid regulatory tightening and technology-driven complexity

Outsourced analytical testing has evolved from a cost-avoidance tactic into a strategic capability that shapes device development pathways, regulatory trajectories, and market access. As medical device complexity increases and regulatory scrutiny tightens, manufacturers and clinical sponsors are increasingly dependent on external laboratories to deliver specialized assays, traceable analytical methods, and robust data packages that meet global submission standards. Consequently, the decision to outsource is no longer solely transactional; it now represents a core element of product planning, quality strategy, and supply chain resilience.

This introduction frames the subsequent analysis by highlighting three interdependent drivers: regulatory harmonization that demands rigorous method validation and documentation; technological maturation across instrumentation and data analytics that expands the scope of achievable testing; and shifting commercial dynamics that favor flexible laboratory partnerships over fixed capital investment. These drivers compel organizations to revisit vendor qualification criteria, to redesign testing strategies around capability fit rather than price alone, and to invest in governance practices that preserve chain-of-custody and data integrity. Moving forward, stakeholders who treat analytical testing as an integrated element of development and post-market surveillance will be better positioned to accelerate approvals and mitigate lifecycle risks.

How converging technological, regulatory, and supply chain forces are reshaping outsourced analytical testing for medical devices and demanding new partnership models

The landscape for medical device analytical testing is undergoing transformative shifts as new technologies, regulatory expectations, and commercial models converge. High-resolution instrumentation such as mass spectrometry and advanced microscopy are enabling deeper characterization of materials and biological interactions, which in turn raises expectations for the granularity and reproducibility of test results. At the same time, the integration of informatics and laboratory automation is compressing cycle times and enabling greater throughput without sacrificing data traceability.

Concurrently, regulatory authorities are emphasizing real-world evidence and post-market surveillance, prompting sponsors to design testing regimes that extend beyond premarket certification. This shift incentivizes ongoing partnerships with contract laboratories that can scale longitudinal testing programs and support regulatory queries. Moreover, geopolitical pressures and supply chain fragility are driving manufacturers to diversify analytical capacity, combining in-house capabilities with geographically distributed third-party providers. Collectively, these forces are reshaping procurement practices, elevating vendor risk management, and demanding that analytical partners demonstrate both technical depth and commercial agility.

Examining how evolving tariff dynamics are compelling localization, supply diversification, and contractual resilience across analytical testing service delivery

Tariff policy changes and trade measures can materially affect the cost base and operational design of outsourced analytical testing, particularly when laboratories rely on cross-border supply of instruments, reagents, and specialty consumables. Increased duties on imported equipment may lengthen procurement cycles for instrument upgrades and force some providers to delay capital investments or seek alternative suppliers. In response, laboratories may reprice certain service lines, renegotiate supplier agreements, or reengineer workflows to reduce reliance on tariff-impacted inputs.

Beyond direct cost effects, tariff-induced shifts can catalyze strategic decisions by both sponsors and service providers. For example, device manufacturers may prioritize testing partners with local presence to reduce exposure to import volatility, or they may push for bundled agreements that fix pricing and delivery terms across multiple jurisdictions. Providers that can demonstrate localized sourcing, alternative reagent formulations, or the ability to qualify equivalent instrumentation will have a comparative advantage. In short, tariff dynamics in 2025 and beyond will accelerate localization, influence capital allocation decisions, and prompt more explicit contractual language around pricing adjustments and contingency planning.

Segment-driven insights that connect testing modalities, device classes, phases, and technologies to procurement choices and regulatory evidence requirements

A nuanced segmentation framework helps stakeholders align testing strategies with device risk profiles, regulatory needs, and commercial timelines. Based on Testing Type, market studies distinguish Biological Testing, Chemical Testing, Microbiological Testing, and Physical Testing, with Biological Testing further disaggregated into Biocompatibility Testing, Cytotoxicity Testing, and Hemocompatibility Testing, which clarifies the specific biosafety and materials interaction challenges facing implantable devices. Based on Device Class, the segmentation spans Class I, Class II, and Class III devices, reflecting ascending regulatory rigor and the corresponding depth of documentation and analytical evidence required for higher risk classes.

Based on Device Type, the analysis covers Diagnostics, Drug Delivery Devices, Implants, Monitoring Equipment, and Surgical Instruments, with Implants further categorized into Cardiovascular Implants, Dental Implants, and Orthopedic Implants, enabling tailored analytical approaches for materials, wear debris, and long-term biostability. Based on Test Phase, the market differentiates Clinical and Preclinical testing, where Clinical is further segmented into Phase I, Phase II, Phase III, and Phase IV, underscoring the different objectives and statistical rigor at each stage. Based on Technology, assessments include Chromatography, Mass Spectrometry, Microscopy, and Spectroscopy, and Chromatography is further divided into Gas Chromatography and High Performance Liquid Chromatography to reflect method selection and sample preparation pathways. Finally, Based on End User, the profile spans Contract Research Organizations, Hospitals & Clinics, and Medical Device Manufacturers, and Based on Service Provider the segmentation contrasts Contract Research Organizations and In-House Laboratories, together revealing how demand-side preferences and supply-side configurations shape procurement, quality systems, and innovation adoption.

How regional regulatory heterogeneity, clinical activity, and local capacity shape divergent procurement practices and testing service expectations

Regional dynamics materially influence how analytical testing services are procured, delivered, and regulated. In the Americas, regulatory convergence and a large medtech ecosystem support a diverse supplier base, with emphasis on rapid turnaround, compliance with stringent traceability standards, and interoperability with North American clinical networks. This fosters demand for high-throughput analytical services and interdisciplinary laboratories that can support both premarket submissions and post-market surveillance activities.

In Europe, Middle East & Africa, regulatory frameworks vary significantly across subregions, leading manufacturers to prioritize providers with demonstrated EU conformity assessment expertise and flexibility to navigate national requirements. Providers that offer pan-regional coverage and harmonized data reporting formats stand out. In the Asia-Pacific region, rapid device innovation, expanding clinical trial activity, and supply chain specialization have driven growth in local laboratory capacity, yet variability in accreditation and local testing mandates means sponsors often adopt hybrid testing strategies that combine regional providers with global partners to meet diverse regulatory expectations. These geographic contrasts drive different supplier selection criteria, risk management practices, and investment priorities.

Competitive dynamics reveal that technical depth, regulatory expertise, and flexible delivery models determine supplier selection and differentiation

Companies leading the analytical testing space typically combine deep technical expertise with demonstrable regulatory experience and a geographically distributed footprint. Top-tier providers invest in method development, rigorous validation protocols, and data management systems that support auditability and repeatability, enabling them to serve high-risk device classes and complex materials. These providers also often maintain cross-functional teams that include analytical chemists, biologists, and regulatory scientists to translate laboratory findings into submission-ready narratives.

Mid-tier and niche providers differentiate through specialized technologies-such as advanced microscopy, targeted mass spectrometry workflows, or bespoke microbiological challenge testing-and by offering consultative services that help clients interpret test outcomes in the context of risk management and clinical performance. Meanwhile, some medical device manufacturers choose to maintain in-house analytical capabilities for core assays while outsourcing specialized or capacity-intensive testing. Overall, competitive positioning is driven by the ability to combine technical depth, transparent quality systems, and flexible service offerings that reduce cycle times without compromising evidentiary standards.

Practical, high-impact steps industry leaders can implement to align vendor qualification, capability mixing, and contractual safeguards with program objectives

To convert insights into action, industry leaders should prioritize three pragmatic steps. First, strengthen vendor qualification frameworks to emphasize method validation traceability, instrument equivalency, and contingency sourcing so that testing continuity is preserved during supply disruptions. Second, invest in partnership architectures that blend in-house capability for mission-critical assays with outsourced specialization for throughput or highly technical analyses, thereby optimizing capital allocation and accelerating project timelines.

Third, align contracting and governance practices with long-term regulatory and commercial objectives by incorporating performance-based milestones, data portability clauses, and agreed protocols for method transfers. By taking these actions, organizations can reduce time-to-decision, mitigate tariff and supply-chain exposure, and ensure that analytical testing becomes an asset in regulatory strategy rather than a potential bottleneck. These measures also create a foundation for scalable and auditable testing programs that support product lifecycles from development through post-market surveillance.

Methodological approach combining practitioner interviews, regulatory guidance review, and technical validation to ensure actionable and verifiable insights

This research synthesizes primary interviews with laboratory directors, regulatory affairs leaders, and procurement executives together with secondary analysis of regulatory guidance documents, instrument vendor specifications, and published scientific literature. Primary inputs prioritized practitioners with experience across implantable devices, diagnostics, and combination products to ensure the findings reflect the full spectrum of analytical testing requirements. Secondary analysis emphasized regulatory guidance from major authorities, peer-reviewed method validation protocols, and technology white papers to cross-verify claims of capability and reproducibility.

Data were curated to highlight recurring challenges-such as method transfer failures, reagent supply disruption, and discrepancies in data formatting-and to surface practical mitigations preferred by sponsors and providers. Quality assurance for the research included triangulation of interview findings, corroboration against public regulatory decisions, and validation of technical assertions with subject-matter experts. This methodology ensures the analysis is grounded in operational realities and offers actionable implications for decision-makers involved in testing procurement and quality strategy.

Concluding perspective on transforming analytical testing from a potential bottleneck into a strategic enabler of device safety, compliance, and commercialization

Analytical testing for medical devices is increasingly strategic, requiring manufacturers and service providers to navigate a complex interplay of technology choices, regulatory expectations, and supply-chain risks. Across device classes and testing modalities, the imperative is to secure reproducible, auditable data that withstands regulatory scrutiny while enabling timely development and commercialization decisions. Consequently, organizations must move beyond transactional procurement and build enduring partnerships that combine technical excellence with contractual clarity.

Looking ahead, the organizations that succeed will be those that proactively integrate testing strategy into product planning, diversify their supplier base to mitigate tariff and logistical disruptions, and invest in data systems that enhance traceability and method transferability. By doing so, they will convert analytical testing from a potential bottleneck into a strategic enabler of product safety, regulatory compliance, and commercial agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Analytical Testing Outsourcing Market, by Testing Type

  • 8.1. Biological Testing
    • 8.1.1. Biocompatibility Testing
    • 8.1.2. Cytotoxicity Testing
    • 8.1.3. Hemocompatibility Testing
  • 8.2. Chemical Testing
  • 8.3. Microbiological Testing
  • 8.4. Physical Testing

9. Medical Device Analytical Testing Outsourcing Market, by Device Class

  • 9.1. Class I
  • 9.2. Class II
  • 9.3. Class III

10. Medical Device Analytical Testing Outsourcing Market, by Device Type

  • 10.1. Diagnostics
  • 10.2. Drug Delivery Devices
  • 10.3. Implants
    • 10.3.1. Cardiovascular Implants
    • 10.3.2. Dental Implants
    • 10.3.3. Orthopedic Implants
  • 10.4. Monitoring Equipment
  • 10.5. Surgical Instruments

11. Medical Device Analytical Testing Outsourcing Market, by Test Phase

  • 11.1. Clinical
    • 11.1.1. Phase I
    • 11.1.2. Phase II
    • 11.1.3. Phase III
    • 11.1.4. Phase IV
  • 11.2. Preclinical

12. Medical Device Analytical Testing Outsourcing Market, by Technology

  • 12.1. Chromatography
    • 12.1.1. Gas Chromatography
    • 12.1.2. High Performance Liquid Chromatography
  • 12.2. Mass Spectrometry
  • 12.3. Microscopy
  • 12.4. Spectroscopy

13. Medical Device Analytical Testing Outsourcing Market, by End User

  • 13.1. Contract Research Organizations
  • 13.2. Hospitals & Clinics
  • 13.3. Medical Device Manufacturers

14. Medical Device Analytical Testing Outsourcing Market, by Service Provider

  • 14.1. Contract Research Organizations
  • 14.2. In-House Laboratories

15. Medical Device Analytical Testing Outsourcing Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Device Analytical Testing Outsourcing Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Device Analytical Testing Outsourcing Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Medical Device Analytical Testing Outsourcing Market

19. China Medical Device Analytical Testing Outsourcing Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Avomeen Analytical Services
  • 20.6. Bioreliance Corporation
  • 20.7. Bureau Veritas SA
  • 20.8. Charles River Laboratories International, Inc.
  • 20.9. Element Materials Technology Group Ltd.
  • 20.10. Eurofins Medical Device Testing
  • 20.11. Eurofins Scientific SE
  • 20.12. Gateway Analytical LLC
  • 20.13. Intertek Group plc
  • 20.14. Lucideon Limited
  • 20.15. Medical Device Testing Services, Inc.
  • 20.16. Medistri SA
  • 20.17. Microbac Laboratories, Inc.
  • 20.18. Nelson Laboratories, LLC
  • 20.19. North American Science Associates, Inc.
  • 20.20. Pacific Biolabs
  • 20.21. SGS SA
  • 20.22. Sterigenics U.S., LLC
  • 20.23. Toxikon Corporation
  • 20.24. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HEMOCOMPATIBILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HEMOCOMPATIBILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HEMOCOMPATIBILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHYSICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHYSICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHYSICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS I, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS I, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS I, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS II, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS II, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS II, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS III, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS III, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLASS III, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MONITORING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MONITORING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MONITORING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE IV, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE IV, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHASE IV, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IN-HOUSE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IN-HOUSE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IN-HOUSE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 228. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 231. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 236. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 238. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS MEDICAL DEVICE ANALYTICAL TE